# Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

> **NCT07476287** · PHASE2 · RECRUITING · sponsor: **Pfizer** · enrollment: 40 (estimated)

## Conditions studied

- Small Cell Lung Cancer
- Small Cell Lung Cancer ( SCLC )
- Transformed Small Cell Lung Cancer
- Lung Neoplasms
- Carcinoma, Small Cell Lung
- Small Cell Cancer Of The Lung

## Interventions

- **DRUG:** PF-08634404
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT07476287
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-15
- **Primary completion:** 2028-03-19
- **Final completion:** 2031-03-19
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476287, "Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07476287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*